Browsing by Author "Burton, P"

Now showing items 1-1 of 1

Recurrent Hospitalization Among Patients With Atrial Fibrillation Undergoing Intracoronary Stenting Treated With 2 Treatment Strategies of Rivaroxaban or a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy.

Arbetter, D; Bode, C; Burton, P; Chi, G; Cohen, M; Daaboul, Y; Fox, KAA; ... (19 authors) (Circulation, 2017-01-24)

BACKGROUND: Patients with atrial fibrillation who undergo intracoronary stenting traditionally are treated with a vitamin K antagonist (VKA) plus dual antiplatelet therapy (DAPT), yet this treatment leads to high risks of ...